HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 42 | 44 | 95.5% | |
| HF004 | 2020 | 41 | 46 | 89.1% | |
| HF006 | 2021 | 67 | 74 | 90.5% | |
| HF006 | 2022 | 77 | 80 | 96.2% | |
| HF006 | 2023 | 109 | 114 | 95.6% |
